Zynex Inc
NASDAQ:ZYXI
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
7.19
13.74
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Zynex Inc
Current Portion of Long-Term Debt
Zynex Inc
Current Portion of Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Zynex Inc
NASDAQ:ZYXI
|
Current Portion of Long-Term Debt
$284k
|
CAGR 3-Years
42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
11%
|
||
Becton Dickinson and Co
NYSE:BDX
|
Current Portion of Long-Term Debt
$2.2B
|
CAGR 3-Years
63%
|
CAGR 5-Years
11%
|
CAGR 10-Years
27%
|
||
Boston Scientific Corp
NYSE:BSX
|
Current Portion of Long-Term Debt
$1.7B
|
CAGR 3-Years
85%
|
CAGR 5-Years
5%
|
CAGR 10-Years
88%
|
||
Stryker Corp
NYSE:SYK
|
Current Portion of Long-Term Debt
$2.2B
|
CAGR 3-Years
361%
|
CAGR 5-Years
33%
|
CAGR 10-Years
11%
|
||
Abbott Laboratories
NYSE:ABT
|
Current Portion of Long-Term Debt
$1.6B
|
CAGR 3-Years
29%
|
CAGR 5-Years
5%
|
CAGR 10-Years
23%
|
||
Intuitive Surgical Inc
NASDAQ:ISRG
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Zynex Inc
Glance View
Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. The company is headquartered in Englewood, Colorado and currently employs 774 full-time employees. The company went IPO on 2002-11-27. The Company’s devices are intended for pain management to reduce reliance on drugs and medications and provide rehabilitation and through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current (IFC), neuromuscular electrical stimulation (NMES) and transcutaneous electrical nerve stimulation (TENS). The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, and E-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Distributed Complementary, which includes Comfortrac/Saunders, JetStream, Knee Braces and LSO Back Braces, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter. CM-1500 is a Zynex fluid monitoring system.
See Also
What is Zynex Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
284k
USD
Based on the financial report for Sep 30, 2024, Zynex Inc's Current Portion of Long-Term Debt amounts to 284k USD.
What is Zynex Inc's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
11%
Over the last year, the Current Portion of Long-Term Debt growth was 42%. The average annual Current Portion of Long-Term Debt growth rates for Zynex Inc have been 42% over the past three years , and 11% over the past ten years .